Melbourne-based startup Lyrebird Well being has just lately raised $12 million in new funding from a enterprise spherical led by 5 V Capital and United Kingdom-based Octopus Ventures, with participation from Startmate.
Launched in 2023, it presents a generative AI-powered scientific documentation software for normal practitioners. Its AI scribe has been built-in into market-leading EMR methods in Australia, reminiscent of Greatest Apply and Gentu.
WHAT IT’S FOR
In a weblog publish, Lyrebird Well being shared that it’s going to utilise its contemporary funds for world enlargement, beginning in the UK.
In February, the startup introduced its first UK partnership with Alder Hey Youngsters’s NHS Basis Belief for a phased implementation of its AI scribe.
“With this increase, we’ll deepen our funding in product high quality, privateness, and security,” founder Kai Van Lieshout added.
MARKET SNAPSHOT
Fellow AI scribe developer, Heidi Well being, additionally based mostly in Melbourne, raked in virtually $17 million in Sequence A funding in March. The startup mentioned these proceeds will go to growing new capabilities of its AI scribe, reminiscent of pre-chart abstract creation. Heidi additionally labored with Telstra Well being to launch its scientific documentation software in February.
In the meantime, Lyrebird additionally just lately secured a partnership with King’s Hospital in Dubai and introduced the combination of its AI software into the pre-consultation platform of Sydney-based well being tech firm HealthShare.
In August final yr, outpatient departments throughout Gold Coast Well being in Queensland underwent the primary stage trial of Lyrebird’s AI scribe.
